Try
SUPERNUS PHARMACEUTICALS, INC.
SUPNUnited States
104 filed reports · 590 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
104 reports · Dec 2013 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 240 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 49 | 236 | Dec 2013 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 38 | 5,415 | Mar 2014 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 13 | 5,373 | Dec 2013 to Dec 2025 |
| Quarterly · 10-Q/ASEC EDGAR | 3 | 578 | Sep 2015 to Jun 2016 |
| Annual · 10-K/ASEC EDGAR | 1 | 339 | Dec 2015 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 3, 2026 | 401 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 3, 2026 | 6 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 5, 2026 | 238 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 5, 2026 | 4 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 2, 2026 | 916 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 24, 2026 | 4 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 255 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 4, 2025 | 4 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 5, 2025 | 139 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 5, 2025 | 4 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 6, 2025 | 142 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 6, 2025 | 6 | Open |
Financial data
590 concepts · 11,941 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial571 concepts · 11,143 facts · Dec 2011 to Jul 2026
- Costs and expenses73 · Dec 2011 to Jun 2026
- Net income loss73 · Dec 2011 to Jun 2026
- Revenue73 · Dec 2011 to Jun 2026
- Cash and cash equivalents at carrying value71 · Dec 2011 to Jun 2026
- Allocated share based compensation expense69 · Dec 2011 to Jun 2026
- Comprehensive income net of tax69 · Dec 2011 to Jun 2026
- Depreciation depletion and amortization69 · Dec 2011 to Jun 2026
- Increase decrease in accounts receivable69 · Dec 2011 to Jun 2026
- Operating income loss69 · Dec 2011 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent69 · Dec 2011 to Jun 2026
- Proceeds from issuance of common stock69 · Dec 2011 to Jun 2026
- Research and development expense69 · Dec 2011 to Jun 2026
- Selling general and administrative expense69 · Dec 2011 to Jun 2026
- Share based compensation69 · Dec 2011 to Jun 2026
- Increase decrease in inventories68 · Dec 2012 to Jun 2026
- Stockholders equity (US GAAP)68 · Dec 2011 to Jun 2026
- Amortization of intangible assets67 · Mar 2013 to Jun 2026
- Net cash provided by used in financing activities67 · Dec 2011 to Jun 2026
- Net cash provided by used in investing activities67 · Dec 2011 to Jun 2026
- Net cash provided by used in operating activities67 · Dec 2011 to Jun 2026
- Accounts receivable net current66 · Dec 2012 to Jun 2026
- Additional paid in capital66 · Dec 2012 to Jun 2026
- Assets66 · Dec 2012 to Jun 2026
- Assets current66 · Dec 2012 to Jun 2026
Product2 concepts · 415 facts · Dec 2016 to Jun 2026
- Revenue414 · Dec 2016 to Jun 2026
- Estimated adjustment for product returns related to prior year sales1 · Dec 2020
Guidance6 concepts · 236 facts · Mar 2014 to Aug 2026
- Revenue Guidance98 · Mar 2014 to Aug 2026
- Operating Income Guidance90 · Mar 2015 to Aug 2026
- Effective Tax Rate Guidance24 · May 2018 to Apr 2022
- Operating Income Guidance (Adjusted (non-GAAP))18 · Feb 2022 to Aug 2026
- Free Cash Flow Guidance4 · Mar 2014 to Nov 2014
- Gross Margin Guidance2 · Aug 2020
Segment11 concepts · 147 facts · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- General and administrative expense (US GAAP)14 · Dec 2022 to Jun 2026
- Marketing expense14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- ONAPGO14 · Dec 2022 to Jun 2026
- Reportable Segment14 · Dec 2022 to Jun 2026
- Research and development expense14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Segment reporting other item amount14 · Dec 2022 to Jun 2026
- Selling expense14 · Dec 2022 to Jun 2026
- Business combination acquisition related costs7 · Dec 2023 to Dec 2025
Segments
562 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis18 members · 386 facts
- Oxtellar XR44 · Dec 2016 to Jun 2026
- Product44 · Dec 2016 to Jun 2026
- Trokendi Xr43 · Dec 2017 to Jun 2026
- APOKYN37 · Dec 2018 to Jun 2026
- Qelbree32 · Dec 2019 to Jun 2026
- Royalty32 · Dec 2016 to Dec 2023
- GOCOVRI29 · Dec 2019 to Jun 2026
- Manufactured Product Other28 · Dec 2020 to Jun 2026
- Royalty License And Other Revenue17 · Dec 2022 to Jun 2026
- MYOBLOC15 · Dec 2018 to Dec 2021
- XADAGO15 · Dec 2018 to Dec 2021
- ONAPGO12 · Dec 2023 to Jun 2026
- Collaboration Revenue11 · Dec 2023 to Jun 2026
- License11 · Dec 2016 to Dec 2020
- License Event Based Milestone6 · Dec 2017 to Jun 2019
- Trokendi XR5 · Dec 2016 to Mar 2019
- Osomolex ER3 · Dec 2019 to Dec 2021
- Royalty And License2 · Mar 2023 to Mar 2024
Statement business segments1 member · 147 facts
- Reportable147 · Dec 2022 to Jun 2026
Product or serviceus-gaap:ProductOrServiceAxis5 members · 29 facts
- Oxtellar XR6 · Mar 2017 to Sep 2018
- Product6 · Mar 2017 to Sep 2018
- Royalty6 · Mar 2017 to Sep 2018
- Trokendi XR6 · Mar 2017 to Sep 2018
- License5 · Mar 2017 to Sep 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.